ALZN

ALZAMEND NEURO INC

ALZN·02262M605·US·Common Stock·Healthcare - Biotechnology-Activist

ALZN (ALZAMEND NEURO INC) is held by 7 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($48,420), VANGUARD FIDUCIARY TRUST CO ($22,281), MORGAN STANLEY ($19,080). Net institutional sentiment: Mixed.

7
Holders
Avg rating(1 Elite)
$105,227
Total Value
50% (10)
Fund Consensus
4 buying - 4 selling
ALZNSmart Money Verdict
View all
Held by 7 funds
1 elite
Who's Trading
InsiderAIAULT MILTON C IIIBuy $109KApr 14, 2026
InsiderAIAULT MILTON C IIISell $4KDec 23, 2025
InsiderHBHorne William B.Sell $7KDec 19, 2025
InsiderMFMcGrath Lynne FaheySell $68.7Oct 23, 2025
InsiderAIAULT MILTON C IIISell $47KOct 9, 2025
InsiderAIAULT MILTON C IIISell $247KOct 8, 2025
ActivistMCMILTON C. AULT, III4.4%Oct 7, 2025
InsiderAIAULT MILTON C IIISell $143KOct 7, 2025
InsiderAIAULT MILTON C IIISell $201KOct 6, 2025
InsiderAIAULT MILTON C IIISell $161KOct 3, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
45,680(+66.1%)$48,4200.0%-43.87%
20
New
21,020$22,2810.0%-37.23%
29
Unchanged
18,000$19,0800.0%-38.54%
0
New
5,231$5,5450.0%-37.23%
24
Decreased
4,504(-81.7%)$4,7740.0%-40.31%
0
New
4,400$4,6640.0%-37.23%
23
Unchanged
437$4630.0%-89.07%
0
Exited
0(-100.0%)$22,6950.0%-2.08%
0
Exited
0(-100.0%)$23,0000.0%-2.08%
0
Exited
0(-100.0%)$780.0%-68.61%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used